chrisvoncsefalvay/vaers-outcomes huggingface dataset:
itching; palpitations; back ache; had an allergic reaction; full blown hives; rash on her face, ears, legs and arms; fever; tired; sore throat; swollen lymph nodes; chills; This is a spontaneous report from a contactable nurse (patient) via a Pfizer-sponsored program. A 41-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot: EJ1685, expiry: Mar2021) intramuscularly on 19Dec2020 at a single dose for covid-19 immunisation. Medical history was reported as none. The patient's concomitant medications were not reported. On 20Dec2020, the patient experienced fever, tired, sore throat, swollen lymph nodes and chills. On 08Jan2021, the patient experienced rash on her face, ears, legs and arms. On 09Jan2021, the patient had an allergic reaction and had full blown hives. It was also reported that the patient experienced itching and back ache on an unspecified date. The patient also experienced palpitation on an unspecified date and she went to the emergency room in which she was prescribed with lorazepam (ATIVAN). The patient was also treated with naproxen (ALEVE) for fever and back ache, steroid (unspecified) for allergic reaction and hives, TRIAMCINOLONE cream for the rash and HYDROXYZINE for the itching. Outcome of the events fever, tired, sore throat, swollen lymph nodes and chills recovered on 21Dec2020 while for the events full blown hives, itching, had an allergic reaction, rash on her face, ears, legs and arms, palpitations and back ache was unknown.
No additional AE; MMRII Expired / Administered; inappropriate age at vaccination; This spontaneous report was received from a registered nurse and refers to potentially 6-day-old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 24-SEP-2021, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar RA 27-3) virus vaccine, live, recombinant human albumin (rHA) (M-M-R II) lot # S029455, expiration date 19-SEP-2021 (exact dose, route of administration and anatomical location were not provided) for prophylaxis (inappropriate age at vaccine administration). No additional adverse event was reported.
localized swelling & erythema 7cm in diameter w/some central induration; tx ice packs
Local injection site reaction to the R upper extremity.  Pt received pneumovax on day one and erythema, edema started on day two and persisted through day three when she was evaluated.  Pt experienced pain and tenderness.  No signs of infection and pt vital signs were stable
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. No concurrent conditions, medical history, allergy/drug reactions and concomitant medications were reported. On 02-JUN-2017, the patient was vaccinated with improperly stored VARIVAX injection, lot # M046004, expiry date: 18-NOV-2018 (dosing details not reported) which was reconstituted with properly stored sterile diluent (MERCK) (lot#, expiry date unknown) for prophylaxis. It was reported that the vaccine was exposed to a temperature range of 6 F to 14 F for a duration of 180 minutes. There was no previous temperature excursion. Data logger was involved. No adverse effects were reported. There were no product quality complaints. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1706USA007776.
One week after receiving the Moderna COVID vaccine I developed a red itchy area around the injection site.  It was approximately 6 in long and 3 in. wide in an oval shape.  I called the health care facility where I received the vaccine and was told to draw a line around the site, take Benadryl and watch for worsening.   I took two Benadryl tablets that day.  The site did not increase in size so I used only one Benadryl tablet on 1-20-21 and Benadryl cream on the site.  The redness did not subside until 1-21-21 when I used 3 Benadryl tablets throughout the day.  The redness is fairly faint on 1-22-21 but still itches when rubbed.  The evening of 1-21-21 I develop a butterfly redness on my face in the evening following a glass of wine which is not usual for me.  Not sure if it is related.
I woke up the day after my first shot with severe eczema covering both hands, with particular intensity on the fingers. The eczema appeared to get worse over the next day or so, but receded around day 3 or 4, leaving completely about a week after the shot. A few days after the shot, I also began developing a light full body rash, particularly on the sides of my torso. Eventually, after everything faded, I began getting some peeling skin on my fingers, which I assume were caused by the eczema.  I went to urgent care when this rash appeared. Here were her notes:  With patient having a recent diagnosis of strep, opted to order a group A strep test that was negative. Patient did not have any exudate noted in the OP. Patient's rash did start after having the COVID-19 vaccine. We will have patient continue to monitor for any increasing symptoms. If symptoms fail to improve or worsen over the next week, will have patient return to the urgent care or follow-up with his primary care provider for further evaluation and treatment. Patient may apply lubricating lotion over the areas. He stated that it was not itchy except for on the hands. He may apply calamine ointment or Benadryl cream to the areas of irritation.
This spontaneous report was received from a pharmacist referred to a patient of unknown age and gender. The patient's relevant medical history, relevant concomitant medications, and relevant past drug history are unknown to the reporter. On 22-MAY-2013 the patient was vaccinated with PNEUMOVAX23 (Lot# unspecified), dose 1 (dose, frequency, route and indication unspecified). On 24-MAY-2014, the patient was given another PNEUMOVAX 23 by a nurse who didn't realize that the patient had already received PNEUMOVAX 23 2 days ago. It was unknown if there is relevant lab data. As of 24-MAY-2014, the outcome of the event was unknown. Additional information is not expected.
Aplastic Anemia; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 12Apr2022 at 15:15 as dose 4 (booster), single (Lot number: FK9894) at the age of 71 years for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: NEXIUM [ESOMEPRAZOLE SODIUM]; FLONASE [MOMETASONE FUROATE]. Vaccination history included: Bnt162b2 (DOSE 3, SINGLE, Lot number: FC3181), for COVID-19 immunization; Bnt162b2 (DOSE 2, SINGLE, Lot number: EL9265), for COVID-19 immunization; Bnt162b2 (DOSE 1, SINGLE, Lot number: EL3248), for COVID-19 immunization. The following information was reported: APLASTIC ANAEMIA (hospitalization, disability, medically significant, life threatening) with onset Apr2022, outcome "recovering", described as "Aplastic Anemia". The patient was hospitalized for aplastic anaemia (start date: 28Apr2022, discharge date: 08May2022, hospitalization duration: 11 day(s)). The event "aplastic anemia" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: Nasal Swab. Therapeutic measures were taken as a result of aplastic anaemia from May2022 to present. Clinical course: Booster vaccine on 12Apr2022. Patient started bruising and getting tired with a fast heartbeat with minimal exertion that week. I was admitted to the hospital on 28Apr2022 and diagnosed with Aplastic Anemia on 06May2022.
Has a fever; Started losing her voice; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Has a fever) and APHONIA (Started losing her voice) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Not provided) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included Hypertension, High cholesterol and Diabetes. Concomitant products included OMEPRAZOLE.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PYREXIA (Has a fever) and APHONIA (Started losing her voice). At the time of the report, PYREXIA (Has a fever) and APHONIA (Started losing her voice) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Day of: Headache started at 3:00 pm same day, left arm pain ,  fatigue, fever/ chills at 1;00 AM.   Day 1 (Thursday) headache, fatigue, arm pain  Day 2  slight headache no Tylenol, fatigue, no arm pai
Pt complained that her Left shoulder was very sore and had limited movement after her injection on 11/19/21.  She called our clinic today to report her symptoms. She does not feel is a reaction to the vaccine but a placement issue.  She currently states she cannot move her shoulder and is going to see her PCP today.
pt recv vax 25MAR97 & 40min later exp a bad h/a, a lot of lethargy & felt very hot;tx w/ibuprofen;26MAR97 h/a is slowly resolving & is gaining back energy;
Soreness of the arm; Slight Headache; Chills; Nauseous; Freezing; Sweating; Gassy; I had a feeling that i had to run to the bathroom but nothing ever came out; ASpontaneous report was received from a Healthcare Professional concerning a 63-year old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced freezing, chills, sweating, nauseous, gassy, had a feeling that I had to run to the bathroom but nothing came out, slight headache and soreness of the arm.  The patient's medical history was not provided. Concomitant medications reported included paracetamol.   On 29 Dec 2020, approximately 1 day prior to the onset of the events, the patient received her first of two planned doses of mRNA-1273 intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 29 Dec 2020, the patient woke up that evening freezing, had chills, was sweating, nauseous, gassy, and had a feeling she had to run to the bathroom but nothing came out. These symptoms only lasted the night.   On 30 Dec 2020, she had a slight headache and soreness of the arm. Treatment for the event included paracetamol.   Action taken with mRNA-1273 in response to the events was not reported.  The event(s) freezing, chills, sweating, nauseous, gassy, and had a feeling that I had to run to the bathroom but nothing came out, were considered resolved on 29 Dec 2020. The outcome of the event(s) slight headache and soreness of the arm were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This spontaneous report as received from a registered nurse (R.N.) refers to an unspecified number of patients of unspecified age and gender. Medical history and concurrent conditions were not reported. On 03-SEP-2015, the patients were vaccinated with improperly stored ZOSTAVAX (lot # L000449 and expiry date: 08-MAR-2016) (dose, frequency, route and site of administration not reported). No concomitant medications were reported. No adverse symptoms were reported. The outcome of incorrect product storage was unknown. No product quality complaint (PQC) was filed. No further information was provided. This is one of the 3 reports from the same reporter. Additional information has been requested.
This spontaneous case reported by a consumer, describes the occurrence of pruritus (itching all over the body) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 039B21A) for COVID-19 immunization. No medical history reported. On Feb 22, 2022, patient received the third dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Feb 22, 2022, patient experienced pruritus (itching all over the body). Patient treated with Benadryl (diphenhydramine hydrochloride) at an unspecified dose and frequency. At the time of the report, pruritus (itching all over the body) outcome: unknown. No concomitant medication reported.
Information has been received from a RN from the HD concerning "several cases of people who in 1968 were vaccinated with a monovalent measles vaccine and are presently exhibiting measles type symptoms". The nurse stated she did not feel this was measles, but something else. Unspecified medical attention was sought. Follow up information from the nurse indicated that there were numerous cases of rah illnesses that proved not to be measles. There was no definitive diagnosis for these cases and she was not able to elaborate. She also reported 15 confirmed cases of measles and one individual developed a rash that tested negative for measles. Additional information has been requested.
pt was moved from one bed to another @ approx 9PM p/being asleep awhile;cried hysterically when moved;was given APAP-felt warm & sweaty family member reports child rolling eyes back & shaking;unclear regarding length of event;to ER;
Patient reported diarrhea today x 2; had fever yesterday w/ 37.5C, no fever at the clinic today with temp of 98.2F. C/o sore throat and skin redness on her right deltoid with pain, soft to touch with measurements of 7cm x 13cm.
5 minutes post-vaccination, struggled to breathe, felt itchiness in throat, light-headed, dizziness, & tightness in chest.
MUSCLE ACHES IN SHOULDER AND LEGS; TIREDNESS; FELT LIKE VOMITING; BODY ACHES; This spontaneous report received from a patient concerned an elderly male. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and expiry: 26-MAY-2021) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced body aches. On 06-APR-2021, the subject experienced felt like vomiting. On 06-APR-2021 21:00, the subject experienced tiredness. On 07-APR-2021, the subject experienced muscle aches in shoulder and legs. On 08-APR-2021, treatment medications included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, and muscle aches in shoulder and legs on 09-APR-2021, tiredness on 07-APR-2021, and felt like vomiting on 06-APR-2021. This report was non-serious.
I had regular symptoms of exhaustion, body aches and low-grade fever (nothing over 100.9) for the first 6 days or so. The body aches got worse into the week of Dec 27th - to the point where I could not get out of bed. The body aches continued and so did the exhaustion. On new years eve, I started having chest pains and so I went to the Emergency room. They found that I did not have a heart attack so they sent me home. I followed up with a doctor at Facility (Dr.) and I briefly mentioned that I think this was related to the COVID booster. He told me that it is highly unlikely that it is the vaccine and that adverse reactions are minimal. To this day I am still easily exhausted and have to lie down often. Dr. ordered labwork and it showed some inflammation and tested positive for ANA. Saw  rheumatologist today and again, I expressed my concerns that this is all related to the booster shot. He listened and told me there is a chance it could be, but that we are going to rule out everything else first.
noticed a dramatic improvement in my headaches (sinus and migraine). I've had these headaches since I was a child; This is a spontaneous report from a contactable consumer (Patient) via Pfizer-sponsored program. A 38-year-old female patient received first and second dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCUBE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1st dose, single dose, via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 2nd dose, single dose for covid-19 immunisation. Medical history included headaches (sinus and migraine). The patient concomitant medications were not reported.  On an unspecified date, the patient noticed a dramatic improvement in headaches (sinus and migraine). She had these headaches since she was a child. She reported that she had both covid vaccine doses and it was about a month out from her 2nd shot. She just wanted report that she had noticed a dramatic improvement in her headaches (sinus and migraine). She had these headaches since she was a child. She did not know if there was a connection or not but she wanted to bring it to our attention. The outcome was unknown.
Severe chills 9:00pm-10:30pm, profuse sweating, sore upper arm (injection site) day of injection. Bad headache 10/12/2017 most of the day (day after injection).
Pt recvd vax 1NOV93 & 2NOV93 the pt devel congestive heart failure & was hospitalized;
Following day-sore arm and headache.  On day 18 and 19 petechiae noted on the dorsum of both feet, with numbness over the medial malleolus on the right.  The petechiae resolved in 2 days. Numbness persists.  Primary care notified..  ASA discontinued immediately on observation.
had an inflammatory reaction; Sharp pain in stomach; Pain in foot, Pain gets worse specially at night; Drawing down the right side of the face; tiredness; Sleep excessive; Pain in eye; bruising; neck pain; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (neck pain), HYPERSOMNIA (Sleep excessive), EYE PAIN (Pain in eye), CONTUSION (bruising) and INFLAMMATION (had an inflammatory reaction) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Flu (At the age of 15 the patient took the Compazine to treat the flu. recalled experiences of muscle twitches in her face which are very painful and affected her tongue and eye), Migraine (Headaches and nausea from migraine) and Knee replacement (Full knee replacement) in 2014. Concurrent medical conditions included Hypertension and High cholesterol. Concomitant products included PAROXETINE HYDROCHLORIDE (PAXIL [PAROXETINE HYDROCHLORIDE]), LEVOTHYROXINE SODIUM (SYNTHROID), LOSARTAN, ATORVASTATIN and BUTALBITAL;CAFFEINE;CODEINE PHOSPHATE;PARACETAMOL for an unknown indication, PROMETHAZINE.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced NECK PAIN (neck pain) and CONTUSION (bruising). On an unknown date, the patient experienced HYPERSOMNIA (Sleep excessive), EYE PAIN (Pain in eye), INFLAMMATION (had an inflammatory reaction), ABDOMINAL PAIN UPPER (Sharp pain in stomach), PAIN IN EXTREMITY (Pain in foot, Pain gets worse specially at night), DYSMORPHISM (Drawing down the right side of the face) and FATIGUE (tiredness). The patient was treated with LOSARTAN at a dose of 50 mg. At the time of the report, NECK PAIN (neck pain) and EYE PAIN (Pain in eye) had resolved, HYPERSOMNIA (Sleep excessive), CONTUSION (bruising), ABDOMINAL PAIN UPPER (Sharp pain in stomach), PAIN IN EXTREMITY (Pain in foot, Pain gets worse specially at night), DYSMORPHISM (Drawing down the right side of the face) and FATIGUE (tiredness) outcome was unknown and INFLAMMATION (had an inflammatory reaction) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
No additional AE reported; Nurse reporting a patient was administered PROQUAD after a temperature excursion.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history and  concurrent conditions were not reported. Concomitant therapies were not reported.  On 06-JAN-2022, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, at a dose of 0.5 milliliter, lot #U019287, expiration date: 15-DEC-2022, administered for prophylaxis (strength, and route of administration were not provided) after a temperature excursion of 12.4F Fahrenheit (°F) during a time frame of 0 hours, 20 minutes and 0 seconds. Previous temperature excursion was of 6°F to 14°F (11.6F) for 0 hours, 25 minutes and 0 seconds.  No additional adverse events were reported.
In a few days, my vision became blurry. I went to see my eye doctor March 19, 2021. He said my vision went down by 400%. He suggested I report this event to Moderna.
vomiting; chills; This is a spontaneous report from a non-contactable physician reported for himself. A 36-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via unspecified route of administration at left arm on 20Dec2020 06:45 at single dose for Covid-19 immunization. Medical history included GERD. The patient was not diagnosed with Covid-19 prior to vaccination. Concomitant medications included omeprazole from unspecified date for unspecified indication. The patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine. The patient previously took ibuprofen and experienced allergies. The patient has not been tested for Covid-19 since the vaccination. On 21Dec2020 06:45 (24 hours after shot), the patient experienced vomiting and chills, lasted 4 hours (21Dec2020 10:45). The patient received treatment of promethazine for vomiting. The outcome of the events was recovered. The reporter considered the events non-serious; did not results in death, was not life threatening, did not cause/prolong hospitalization, was not disabling/incapacitating, and no congenital anomaly/birth defect.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Headache, blurred vision, muscle joint pain, chills, numbness and tingling in injection arm. Fell as a result.
Following vaccination, the pt found out that she was 1.5 weeks pregnant at the time of the second vaccination and her LMP was approximately 8/4/00. Subsequently on 9/16/00, she miscarried her fetus. It was reported that the pt sought unspecified medical attention. Additional information has been requested. On 8/16/00 pt had soreness of her arm at the injection site and was feverish at the injection site.  Follow up on 03/28/2001: "Lot number for vaccine #1 is not provided."